Confirmed overall response rate (ORR) was 37.5% for pelareorep + paclitaxel and 13.3% for paclitaxel. As previously reported, ORRs at week 16 (the trial's primary endpoint) in the pelareorep + ...

This week, the FDA approved Eli Lilly’s LLY eczema drug, Ebglyss (lebrikizumab), and the expanded use of Novartis’ NVS ...

Kajeet and Avery Telehealth announced a strategic partnership. The FDA has approved Apple’s sleep apnea detection feature.

Detailed price information for Galmed Pharmaceutica (GLMD-Q) from The Globe and Mail including charting and trades.

Breastfeeding through the first year of infants' lives can lower their risk of asthma by colonizing their bodies with a ...

Cannabis extract taken by the mouth could potentially provide additional relief for patients with chemotherapy-induced nausea ...

The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...

In the oncology world, there’s been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years.

Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...

New research shows about one in eight of all cancer cases are linked to common infections like HPV, Hepatitis B and C and H. pylori. NBC News medical contributor Dr. Natalie Azar joins TODAY to share ...